Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Channa Striatus Extract on Serum Albumin and High Sensitive C-Reactive Protein in End-Stage Renal Disease Patients

NCT05614362 is registered in ClinicalTrials.gov with Universitas Sebelas Maret as lead sponsor.

NCT NCT05614362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05614362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Channa Striatus Extract on Serum Albumin and High Sensitive C-Reactive Protein in End-Stage Renal Disease Patients
Lead sponsor
Universitas Sebelas Maret
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2021
Completion date
March 1, 2021
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, inflammation